In preclinical IBD mice experiments, administration of mu-opioid receptor (MOR) agonists or δ opioid agonists alleviated TNBS-induced murine colitis, whereas MOR-deficient mice showed higher vulnerability to colitis compared to the wild-type mice [10,15]. The gene discussed is OPRM1; the disease is inflammatory bowel disease.